Advertisement

Topics

Harpoon Therapeutics Launches Immuno-Oncology Pipeline With Compelling Data From Lead Programs at the 2018 American Association for Cancer Research (AACR) Annual Meeting

09:00 EDT 16 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Preclinical Data Showcase New T Cell Engaging Platform (TriTACâ„¢) and Lead Drugs, HPN424 and HPN536, Targeting Prostate Cancer and Other Solid Tumors Harpoon Therapeutics, a biotechnology company pioneering a new class of ...

Other Sources for this Article

Harpoon Therapeutics:
Kinkead Communications, Inc.
Susan Kinkead, 415-509-3610
susan@kinkeadcomm.com

NEXT ARTICLE

More From BioPortfolio on "Harpoon Therapeutics Launches Immuno-Oncology Pipeline With Compelling Data From Lead Programs at the 2018 American Association for Cancer Research (AACR) Annual Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...